These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9653889)

  • 1. Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.
    Scheuermann M; Dietz R; Willenbrock R
    Eur J Pharmacol; 1998 Apr; 347(2-3):245-52. PubMed ID: 9653889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
    Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
    Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
    Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
    Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
    Scott JM; Barclay PL; Shepperson NB
    Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide is involved in renal actions of moxonidine.
    Mukaddam-Daher S; Gutkowska J
    Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients.
    Geny B; Hardy H; Lonsdorfer J; Eisenmann B; Haberey P; Piquard F
    Hypertension; 1999 Apr; 33(4):969-74. PubMed ID: 10205232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Sybertz E
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):635-40. PubMed ID: 1380608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
    Willenbrock R; Scheuermann M; Thibault G; Haass M; Höhnel K; Bohlender J; Luft FC; Dietz R
    Cardiovasc Res; 1999 Jun; 42(3):733-42. PubMed ID: 10533614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.
    Charles CJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG; Protter A; Kosoglou T
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R373-80. PubMed ID: 8770137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP.
    Campbell HT; Lightfoot BO; Sklar AH
    Proc Soc Exp Biol Med; 1988 Dec; 189(3):317-24. PubMed ID: 2849771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids potentiate the action of atrial natriuretic polypeptide in adrenalectomized rats.
    Hayamizu S; Kanda K; Ohmori S; Murata Y; Seo H
    Endocrinology; 1994 Dec; 135(6):2459-64. PubMed ID: 7988432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
    Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
    Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.